Lungs News and Research

RSS

Yale University scientists synthesize lomaiviticin that appears to destroy cancer stem cells

A team of Yale University scientists has synthesized for the first time a chemical compound called lomaiviticin aglycon, leading to the development of a new class of molecules that appear to target and destroy cancer stem cells.

1 Feb 2011

Vitamin D deficiency linked to lung disease, poor lung function: Study

For the study lead researcher Dr. Graeme Zosky a research fellow at the Telethon Institute for Child Health Research in Subiaco, WA, compared two-week-old mice with vitamin D deficiency to normal mice. He noted that mice with a vitamin D deficiency had weaker lungs and that the difference was substantial.

1 Feb 2011

Smoking kills, it’s as simple as that!

Australia’s Department of Health and Ageing yesterday (Monday) launched its most focused anti-tobacco campaign with a new TV adverts graphically linking smoking with lung cancer. The message of the $61 million campaign says, “Every cigarette you smoke brings cancer closer.”

1 Feb 2011

Simple hTERT analysis may provide useful prognostic tool in advanced non-small cell lung cancer

High levels of circulating DNA may indicate faster progression of lung cancer and lower overall survival, according to a study published in the February edition of the Journal of Thoracic Oncology, the official publication of the International Association for the Study of Lung Cancer (IASLC).

1 Feb 2011

IASLC publishes new international multidisciplinary classification for lung adenocarcinoma

Three of the world's top lung associations have published a new international multidisciplinary classification of lung adenocarcinoma, the first revision to the classification in six years.

1 Feb 2011

News briefs from February issue of journal Chest

New research shows that vitamin D deficiency is prevalent among patients with interstitial lung disease (ILD), with the largest prevalence seen in patients with concurrent connective tissue disease (CTD).

1 Feb 2011

Health Canada approves Microsulis Medical's Accu2i percutaneous microwave tissue ablation system

Microsulis Medical Limited, the leading company in microwave technology for medical devices, today announced that it has received approval from Health Canada for the Acculis Accu2i percutaneous microwave tissue ablation system for the coagulation of soft tissue during surgical procedures.

1 Feb 2011

Covidien announces limited release of Endo GIA curved tip and black reloads with Tri-Staple technology

Covidien, a leading global provider of healthcare products, today announced that its new Endo GIA curved tip and black reloads with Tri-Staple technology are available in limited release with a full U.S. roll out expected by mid-year.

1 Feb 2011

MAP Pharmaceuticals, Allergan collaborate for LEVADEX to treat acute migraine in adults

Allergan, and MAP Pharmaceuticals, today announced a collaboration within the United States for LEVADEX, a self-administered, orally inhaled therapy that has completed Phase III clinical development for the treatment of acute migraine in adults.

31 Jan 2011

National Jewish Health scientists identify signaling pathway for ALI

Researchers at National Jewish Health have discovered a signaling pathway that is crucial to the devastating effects of acute lung injury. The data, obtained from cells, animals and ALI patients, suggest several potential therapeutic targets. Experimental blockade of one of the targets significantly reduced flooding of the lungs that is the hallmark of ALI.

31 Jan 2011

Scientists to commence new DNA vaccine trial for use in patients with leukemia

A new cancer treatment which strengthens a patient's immune system and enables them to fight the disease more effectively is being trialled on patients for the first time in the UK. The treatment will use a new DNA vaccine, developed by scientists from the University of Southampton, which will treat a selected group of volunteers who have either chronic or acute myeloid leukaemia - two forms of bone marrow and blood cancer.

31 Jan 2011

New nicotine addiction mechanism revealed

A new discovery has shown why some people cannot give up tobacco and may lead to new anti-smoking treatments. The researchers have found a brain pathway which when defective leads to an uncontrollable desire to smoke. This is a “sub-unit” of a receptor protein sensitive to nicotine.

31 Jan 2011

$61 million anti-tobacco campaign launched to prevent lung cancer

The Australian Federal Government is backing a $61 million advertising campaign to stop smoking. This is the nation’s biggest anti-tobacco campaign. The message is graphic and simple: every cigarette brings cancer closer. Health groups have backed the campaign but advertising industry experts say the public has become increasingly immune to scare campaigns.

31 Jan 2011

Budget woes lead states to seek ways to ease Medicaid's requirements

While The Hill reports that CMS administrator Donald Berwick says his agency is trying to help states find solutions, National Journal notes that mounting budgetary pressure has put the program in "dire fiscal straits."

29 Jan 2011

Apple Valley Medical Clinic inaugurates new Sleep Center to provide quality care

The Apple Valley Medical Clinic has opened a new Sleep Center, located at 15100 Galaxie Avenue in Apple Valley. The center, under the medical direction of Scott Benson, M.D., a family medicine physician with the Apple Valley Medical Clinic, offers preventive care, diagnosis and treatment of sleep disorders.

28 Jan 2011

New study links vitamin D deficiency with deficits in altered lung structure and function

Previously linked to the severity of asthma and chronic obstructive pulmonary disease in humans, vitamin D deficiency has now been shown to alter lung structure and function in young mice. The new study, conducted by researchers in Australia, offers the first concrete evidence linking vitamin D deficiency with deficits in lung function and altered lung structure.

28 Jan 2011

Tarceva Phase III EURTAC study in NSCLC patients with EGFR activating mutations meets primary endpoint

Genentech, a member of the Roche Group and OSI Pharmaceuticals, a wholly owned subsidiary of Astellas U.S. Holding Inc., a holding company owned by Astellas Pharma Inc., today announced that an independent data monitoring committee has recommended that the Phase III EURTAC study be stopped early because the study met its primary endpoint.

28 Jan 2011

McGill, GSK enter collaborative research agreement on cystic fibrosis

McGill University and GlaxoSmithKline plc have signed a collaboration agreement to develop a potential breakthrough approach to treat cystic fibrosis, a fatal genetic disease. The trans-Atlantic effort between researchers from McGill's Faculty of Medicine and their GSK collaborators in the UK, will focus on developing molecules that could treat the disease by correcting the dysfunction caused by the mutated gene.

28 Jan 2011

Interim results from ganetespib Phase 2 trial in NSCLC to be presented at 11th IASLC annual meeting

Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that Dr. Jonathan Goldman, M.D., Premiere Oncology will present interim results from a Phase 2 trial of ganetespib in non-small cell lung cancer at the International Association for the Study of Lung Cancer 11th Annual Targeted Therapies for the Treatment of Lung Cancer Meeting.

28 Jan 2011

Discovery of aldose reductase enzyme can result in new therapies for asthma and COPD

Researchers have proved that a single "master switch" enzyme, known as aldose reductase, is key in producing excess mucous that clogs the airways of people with asthma and chronic obstructive pulmonary disease.

28 Jan 2011

Lungs News and Research

Yale University scientists synthesize lomaiviticin that appears to destroy cancer stem cells

Vitamin D deficiency linked to lung disease, poor lung function: Study

Smoking kills, it’s as simple as that!

Simple hTERT analysis may provide useful prognostic tool in advanced non-small cell lung cancer

IASLC publishes new international multidisciplinary classification for lung adenocarcinoma

News briefs from February issue of journal Chest

Health Canada approves Microsulis Medical's Accu2i percutaneous microwave tissue ablation system

Covidien announces limited release of Endo GIA curved tip and black reloads with Tri-Staple technology

MAP Pharmaceuticals, Allergan collaborate for LEVADEX to treat acute migraine in adults

National Jewish Health scientists identify signaling pathway for ALI

Scientists to commence new DNA vaccine trial for use in patients with leukemia

New nicotine addiction mechanism revealed

$61 million anti-tobacco campaign launched to prevent lung cancer

Budget woes lead states to seek ways to ease Medicaid's requirements

Apple Valley Medical Clinic inaugurates new Sleep Center to provide quality care

New study links vitamin D deficiency with deficits in altered lung structure and function

Tarceva Phase III EURTAC study in NSCLC patients with EGFR activating mutations meets primary endpoint

McGill, GSK enter collaborative research agreement on cystic fibrosis

Interim results from ganetespib Phase 2 trial in NSCLC to be presented at 11th IASLC annual meeting

Discovery of aldose reductase enzyme can result in new therapies for asthma and COPD

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News